Results 51 to 60 of about 22,604 (146)
Background Like other viral infections, severe acute respiratory syndrome coronavirus-2 infection could affect different human body systems, including host immune responses. Three years after its pandemic, we learn more about this novel coronavirus.
Ali Amanati+7 more
doaj +1 more source
SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA
We report persistent severe acute respiratory syndrome coronavirus 2 infection in a patient with HIV/AIDS; the virus developed spike N terminal domain and receptor binding domain neutralization resistance mutations.
Seth A. Hoffman+13 more
doaj +1 more source
Background: Beginning on March 16, 2020, nonurgent scheduled operations at a large, urban, safety net medical center were canceled. The purpose of this study was to determine complications associated with severe acute respiratory syndrome coronavirus 2 ...
Rachel E. Sargent, MD+5 more
doaj
Background Coronavirus disease 2019, caused by the severe acute respiratory syndrome coronavirus 2, has a broad clinical spectrum, from asymptomatic to multi-organ dysfunction.
Khurram Khaliq Bhinder+5 more
doaj +1 more source
Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged by the end of 2019 and rapidly spread in 2020. At present, it is of utmost importance to understand the biology of the virus, rapidly assess the treatment potential of existing drugs, and develop new active compounds.
Milewska, Aleksandra+14 more
openaire +4 more sources
Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection
Purpose of review Despite its crucial role in protection against viral infections, mucosal immunity has been largely understudied in the context of coronavirus disease 2019 (COVID-19). This review outlines the current evidence about the role of mucosal immune responses in the clearance of severe acute respiratory syndrome ...
Fröberg, J.+2 more
openaire +5 more sources
Experience With Pretravel Testing for SARS-CoV-2 at an Academic Medical Center
International travel has been a significant factor in the coronavirus disease 2019 pandemic. Many countries and airlines have implemented travel restrictions to limit the spread of the causative agent, severe acute respiratory syndrome coronavirus-2.
Katherine L. Imborek MD+5 more
doaj +1 more source
Early Introduction of Severe Acute Respiratory Syndrome Coronavirus 2 into Europe [PDF]
Early infections with severe acute respiratory syndrome coronavirus 2 in Europe were detected in travelers from Wuhan, China, in January 2020. In 1 tour group, 5 of 30 members were ill; 3 cases were laboratory confirmed. In addition, a healthcare worker was infected. This event documents early importation and subsequent spread of the virus in Europe.
Alexis Ardoin+12 more
openaire +4 more sources
Background The topic of natural immunity related to severe acute respiratory syndrome coronavirus 2 remains controversial. Although evidence suggests postinfection immunity can be achieved, there have been reported cases of reinfection with similar or ...
Nimrah Bader+2 more
doaj +1 more source
Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation [PDF]
Previous studies on the pneumonia outbreak caused by the 2019 novel coronavirus disease (COVID-19) were based on information from the general population. However, limited data was available for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reactivation.
Ye, Guangming+7 more
openaire +3 more sources